Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

SARS-CoV-2 target regions

enabled by data from GSAID Logo

EPI_ISL ID Virus name Region Country Collection Date Navigate
EPI_ISL ID: EPI_ISL_19389753 Virus name: hCoV-19/Canada/ON-PHL-202413068/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19389749 Virus name: hCoV-19/Canada/ON-PHL-202413064/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19389746 Virus name: hCoV-19/Canada/ON-PHL-202413061/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19389745 Virus name: hCoV-19/Canada/ON-PHL-202413060/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19389739 Virus name: hCoV-19/Canada/ON-PHL-202413050/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19389737 Virus name: hCoV-19/Canada/ON-PHL-202413048/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19389694 Virus name: hCoV-19/Canada/ON-PHL-202413004/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19389693 Virus name: hCoV-19/Canada/ON-PHL-202413003/2024 Region: North America Country: Canada Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19388774 Virus name: hCoV-19/Spain/CT-HUVH-EXE07431/2024 Region: Europe Country: Spain Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19388773 Virus name: hCoV-19/Spain/CT-HUVH-EXE07430/2024 Region: Europe Country: Spain Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19388772 Virus name: hCoV-19/Spain/CT-HUVH-EXE07429/2024 Region: Europe Country: Spain Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19388771 Virus name: hCoV-19/Spain/CT-HUVH-EXE07428/2024 Region: Europe Country: Spain Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19388770 Virus name: hCoV-19/Spain/CT-HUVH-EXE07427/2024 Region: Europe Country: Spain Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19388769 Virus name: hCoV-19/Spain/CT-HUVH-EXE07426/2024 Region: Europe Country: Spain Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19388768 Virus name: hCoV-19/Spain/CT-HUVH-EXE07421/2024 Region: Europe Country: Spain Collection Date: 2024-09-03 Go to details
EPI_ISL ID: EPI_ISL_19393130 Virus name: hCoV-19/Japan/FR012-0502/2024 Region: Asia Country: Japan Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19393127 Virus name: hCoV-19/Japan/FR012-0505/2024 Region: Asia Country: Japan Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19393126 Virus name: hCoV-19/Japan/FR012-0506/2024 Region: Asia Country: Japan Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19393125 Virus name: hCoV-19/Japan/FR012-0507/2024 Region: Asia Country: Japan Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19393121 Virus name: hCoV-19/Japan/FR012-0511/2024 Region: Asia Country: Japan Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389809 Virus name: hCoV-19/Canada/ON-PHL-202413128/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389752 Virus name: hCoV-19/Canada/ON-PHL-202413067/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389686 Virus name: hCoV-19/Canada/ON-PHL-202412996/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389758 Virus name: hCoV-19/Canada/ON-PHL-202413073/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19393546 Virus name: hCoV-19/Canada/ON-KHS-04187-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details

Pre-calculated values are obtained by using ThermonucleotideBLAST (Gans JD, Wolinsky M. 2008), which performs in silico simulations with the NAAT methods stored in our database on the selected high-quality (<1% Ns and <0.05% unique amino acid mutations) and full length (>29,000bp) viral genomes made available by GISAID. The aims are both to detect potential target regions of the NAAT methods and to highlight possible differences with the expected reference sequence which might affect the NAAT performance.

The database contains amplicons collected by screening viral shared genomic sequences of SARSCoV- 2 by in silico determination of PCR-based molecular assays to diagnose COVID-19. The information is retrieved periodically. Acknowledgements

GISAID data provided on this website are subject to GISAID's Terms and Conditions